In triple-negative breast cancer, initially immune-enriched tumors with residual disease after neoadjuvant therapy may be ...
Investigators have developed a prognostic model that may identify which patients with MIBC are suitable for bladder-preserving chemoradiation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback